Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases

Published:2016-04-25 Issue:10 Volume:10 Page:1132-1143
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Atreya Imke,Diall Alexandra,Dvorsky Radovan,Atreya Raja,Henninger Christian,Grün Mathias,Hofmann Ute,Schaeffeler Elke,López-Posadas Rocío,Daehn Ilse,Zenker Stefanie,Döbrönti Michael,Neufert Clemens,Billmeier Ulrike,Zundler Sebastian,Fritz Gerhard,Schwab Matthias,Neurath Markus F.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/10/10/1132/13746380/jjw091.pdf

Reference35 articles.

1. Long-Term Effectiveness of Azathioprine in IBD Beyond 4 Years: A European Multicenter Study in 1176 Patients

2. Azathioprine and 6-Mercaptopurine in Crohn Disease

3. Guidelines for the management of inflammatory bowel disease in adults

4. Prefontaine E Macdonald JK Sutherland LR . Azathioprine or 6-mercaptopurine for induction of remission in Crohn’s disease. Cochrane Database Syst Rev 2009:CD000545.

5. Azathioprine: old drug, new actions

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems;Pharmaceutics;2024-09-07

2. VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases;Trends in Immunology;2024-08

3. Use of thiopurines in inflammatory bowel disease: an update;Intestinal Research;2022-01-30

4. From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications;eBioMedicine;2021-12

5. Advances in Thiopurine Drug Delivery: The Current State-of-the-Art;European Journal of Drug Metabolism and Pharmacokinetics;2021-09-06